Clinical Trials
5 trialsNCT01113476 2022-09-02
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00543504 2020-06-30
Bevacizumab in Multiple Phase I Combinations
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00610493 2017-12-08
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01152203 2015-11-18
Bendamustine and Bevacizumab for Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00530907 2015-01-08
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed